A
Ahmad Shabsigh
Researcher at Ohio State University
Publications - Â 79
Citations - Â 5982
Ahmad Shabsigh is an academic researcher from Ohio State University. The author has contributed to research in topics: Prostate & Cystectomy. The author has an hindex of 33, co-authored 74 publications receiving 4831 citations. Previous affiliations of Ahmad Shabsigh include Memorial Sloan Kettering Cancer Center & Columbia University.
Papers
More filters
Journal ArticleDOI
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
James L. Mohler,Emmanuel S. Antonarakis,Andrew J. Armstrong,Anthony V. D'Amico,Brian J. Davis,Tanya B. Dorff,James A. Eastham,Charles Arthur Enke,Thomas A. Farrington,Celestia S. Higano,Eric M. Horwitz,Michael E. Hurwitz,Joseph E. Ippolito,Christopher J. Kane,Michael Kuettel,Joshua M. Lang,Jesse K. McKenney,George J. Netto,David F. Penson,Elizabeth R. Plimack,Julio M. Pow-Sang,Thomas J. Pugh,Sylvia Richey,Mack Roach,Stan Rosenfeld,Edward M. Schaeffer,Ahmad Shabsigh,Eric J. Small,Daniel E. Spratt,Sandy Srinivas,Jonathan D. Tward,Dorothy A. Shead,Deborah A. Freedman-Cass +32 more
TL;DR: The NCCN Guidelines for Prostate Cancer include recommendations regarding diagnosis, risk stratification and workup, treatment options for localized disease, and management of recurrent and advanced disease for clinicians who treat patients with prostate cancer.
Journal ArticleDOI
Defining Early Morbidity of Radical Cystectomy for Patients with Bladder Cancer Using a Standardized Reporting Methodology
Ahmad Shabsigh,Ruslan Korets,Kinjal C. Vora,Christine M. Brooks,Angel M. Cronin,Caroline O. S. Savage,Ganesh V. Raj,Bernard H. Bochner,Guido Dalbagni,Harry W. Herr,S. Machele Donat +10 more
TL;DR: Surgical morbidity following radical cystectomy is significant and, when strict reporting guidelines are incorporated, higher than previously published.
Journal ArticleDOI
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
Dipen J. Parekh,Isildinha M. Reis,Erik P. Castle,Mark L. Gonzalgo,Michael Woods,Robert S. Svatek,Alon Z. Weizer,Badrinath R. Konety,Mathew Tollefson,Tracey L. Krupski,Norm D. Smith,Ahmad Shabsigh,Daniel A. Barocas,Marcus L. Quek,Atreya Dash,Adam S. Kibel,Adam S. Kibel,Lynn Shemanski,Raj S. Pruthi,Jeffrey S. Montgomery,Christopher J. Weight,David Sharp,Sam S. Chang,Michael S. Cookson,Gopal N. Gupta,Alex Gorbonos,Edward Uchio,Eila C. Skinner,Vivek Venkatramani,Nachiketh Soodana-Prakash,Kerri Kendrick,Joseph A. Smith,Ian M. Thompson +32 more
TL;DR: In patients with bladder cancer, robotic Cystectomy was non-inferior to open cystectomy for 2-year progression-free survival and increased adoption of robotic surgery in clinical practice should lead to future randomised trials to assess the true value of this surgical approach in patients with other cancer types.
Journal ArticleDOI
Prostate cancer, version 1.2021: Featured updates to the nccn guidelines
Edward M. Schaeffer,Sandy Srinivas,Emmanuel S. Antonarakis,Andrew J. Armstrong,Justin E. Bekelman,Heather H. Cheng,Anthony V. D'Amico,Brian J. Davis,Neil Desai,Tanya B. Dorff,James A. Eastham,Thomas A. Farrington,Xin Gao,Eric M. Horwitz,Joseph E. Ippolito,Michael Kuettel,Joshua M. Lang,Rana R. McKay,Jesse K. McKenney,George J. Netto,David F. Penson,Julio M. Pow-Sang,Robert E. Reiter,Sylvia Richey,Mack Roach,Stan Rosenfeld,Ahmad Shabsigh,Daniel E. Spratt,Benjamin A. Teply,Jonathan D. Tward,Dorothy A. Shead,Deborah A. Freedman-Cass +31 more
TL;DR: The NCCN Guidelines for Prostate Cancer address staging and risk assessment after a prostate cancer diagnosis and include management options for localized, regional, and metastatic disease Recommendations for disease monitoring and treatment of recurrent disease are also included as mentioned in this paper.
Journal ArticleDOI
Potential Impact of Postoperative Early Complications on the Timing of Adjuvant Chemotherapy in Patients Undergoing Radical Cystectomy: A High-Volume Tertiary Cancer Center Experience
S. Machele Donat,Ahmad Shabsigh,Caroline O. S. Savage,Angel M. Cronin,Bernard H. Bochner,Guido Dalbagni,Harry W. Herr,Matthew I. Milowsky +7 more
TL;DR: It is demonstrated that 30% of patients undergoing radical cystectomies and undergoing RC may not have been able to receive adjuvant chemotherapy due to postoperative complications, and this information should be taken into consideration when planning multimodal therapy.